Neuberger Berman Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53.6M | Buy |
884,303
+127,273
| +17% | +$7.42M | 0.04% | 461 |
|
|
2025
Q4 | $40.8M | Sell |
757,030
-104,148
| -12% | -$5.01M | 0.03% | 507 |
|
|
2025
Q3 | $38.8M | Sell |
861,178
-2,299,874
| -73% | -$107M | 0.03% | 517 |
|
|
2025
Q2 | $146M | Sell |
3,161,052
-1,356,702
| -30% | -$66.6M | 0.11% | 224 |
|
|
2025
Q1 | $275M | Buy |
4,517,754
+1,866,882
| +70% | +$109M | 0.23% | 100 |
|
|
2024
Q4 | $150M | Buy |
2,650,872
+849,460
| +47% | +$47.5M | 0.12% | 211 |
|
|
2024
Q3 | $93.2M | Buy |
1,801,412
+1,217,136
| +208% | +$57.1M | 0.07% | 303 |
|
|
2024
Q2 | $24.3M | Buy |
584,276
+27,301
| +5% | +$1.22M | 0.02% | 592 |
|
|
2024
Q1 | $30.2M | Sell |
556,975
-2,455,456
| -82% | -$125M | 0.03% | 562 |
|
|
2023
Q4 | $155M | Sell |
3,012,431
-2,438,865
| -45% | -$128M | 0.13% | 202 |
|
|
2023
Q3 | $316M | Sell |
5,451,296
-49,643
| -0.9% | -$3.04M | 0.29% | 79 |
|
|
2023
Q2 | $352M | Sell |
5,500,939
-385,385
| -7% | -$25.8M | 0.31% | 75 |
|
|
2023
Q1 | $408M | Buy |
5,886,324
+118,297
| +2% | +$8.34M | 0.38% | 57 |
|
|
2022
Q4 | $415M | Buy |
5,768,027
+1,261,972
| +28% | +$95.2M | 0.41% | 53 |
|
|
2022
Q3 | $321M | Sell |
4,506,055
-329,397
| -7% | -$23.9M | 0.33% | 62 |
|
|
2022
Q2 | $372M | Buy |
4,835,452
+1,053,951
| +28% | +$80.3M | 0.37% | 55 |
|
|
2022
Q1 | $276M | Buy |
3,781,501
+771,582
| +26% | +$51.8M | 0.23% | 113 |
|
|
2021
Q4 | $186M | Sell |
3,009,919
-790,653
| -21% | -$46.4M | 0.15% | 202 |
|
|
2021
Q3 | $224M | Sell |
3,800,572
-10,845
| -0.3% | -$714K | 0.2% | 145 |
|
|
2021
Q2 | $253M | Buy |
3,811,417
+1,462,381
| +62% | +$95.4M | 0.22% | 118 |
|
|
2021
Q1 | $148M | Sell |
2,349,036
-567,808
| -19% | -$35.3M | 0.14% | 217 |
|
|
2020
Q4 | $181M | Buy |
2,916,844
+95,925
| +3% | +$5.9M | 0.19% | 156 |
|
|
2020
Q3 | $170M | Sell |
2,820,919
-462,545
| -14% | -$27.8M | 0.2% | 141 |
|
|
2020
Q2 | $193M | Sell |
3,283,464
-101,458
| -3% | -$6.07M | 0.24% | 108 |
|
|
2020
Q1 | $189M | Sell |
3,384,922
-76,354
| -2% | -$4.67M | 0.29% | 81 |
|
|
2019
Q4 | $222M | Buy |
3,461,276
+1,103,467
| +47% | +$63.2M | 0.26% | 101 |
|
|
2019
Q3 | $120M | Sell |
2,357,809
-315,508
| -12% | -$14.8M | 0.15% | 200 |
|
|
2019
Q2 | $121M | Sell |
2,673,317
-43,435
| -2% | -$2.02M | 0.15% | 197 |
|
|
2019
Q1 | $130M | Buy |
2,716,752
+607,233
| +29% | +$30.2M | 0.16% | 189 |
|
|
2018
Q4 | $110M | Buy |
2,109,519
+347,234
| +20% | +$18.7M | 0.15% | 207 |
|
|
2018
Q3 | $109M | Sell |
1,762,285
-715,856
| -29% | -$42.5M | 0.12% | 243 |
|
|
2018
Q2 | $137M | Sell |
2,478,141
-607,078
| -20% | -$32.8M | 0.15% | 197 |
|
|
2018
Q1 | $195M | Sell |
3,085,219
-87,873
| -3% | -$5.65M | 0.22% | 127 |
|
|
2017
Q4 | $194M | Buy |
3,173,092
+325,704
| +11% | +$20.4M | 0.22% | 138 |
|
|
2017
Q3 | $181M | Sell |
2,847,388
-1,186,277
| -29% | -$69.3M | 0.23% | 135 |
|
|
2017
Q2 | $225M | Sell |
4,033,665
-534,651
| -12% | -$29.1M | 0.29% | 87 |
|
|
2017
Q1 | $248M | Sell |
4,568,316
-914,632
| -17% | -$50.2M | 0.32% | 70 |
|
|
2016
Q4 | $320M | Sell |
5,482,948
-255,834
| -4% | -$14M | 0.43% | 38 |
|
|
2016
Q3 | $309M | Buy |
5,738,782
+208,546
| +4% | +$13.4M | 0.42% | 43 |
|
|
2016
Q2 | $407M | Sell |
5,530,236
-580,494
| -9% | -$41M | 0.56% | 24 |
|
|
2016
Q1 | $390M | Buy |
6,110,730
+126,453
| +2% | +$7.97M | 0.54% | 24 |
|
|
2015
Q4 | $412M | Sell |
5,984,277
-170,914
| -3% | -$11.3M | 0.54% | 26 |
|
|
2015
Q3 | $364M | Sell |
6,155,191
-166,842
| -3% | -$10.6M | 0.47% | 40 |
|
|
2015
Q2 | $421M | Buy |
6,322,033
+22,605
| +0.4% | +$1.49M | 0.47% | 34 |
|
|
2015
Q1 | $406M | Sell |
6,299,428
-850,393
| -12% | -$53.2M | 0.43% | 45 |
|
|
2014
Q4 | $422M | Sell |
7,149,821
-463,425
| -6% | -$26.1M | 0.44% | 49 |
|
|
2014
Q3 | $390M | Sell |
7,613,246
-1,159,048
| -13% | -$57.9M | 0.4% | 49 |
|
|
2014
Q2 | $426M | Buy |
8,772,294
+141,803
| +2% | +$6.99M | 0.42% | 46 |
|
|
2014
Q1 | $448M | Sell |
8,630,491
-824,323
| -9% | -$43.9M | 0.46% | 37 |
|
|
2013
Q4 | $503M | Sell |
9,454,814
-97,443
| -1% | -$4.96M | 0.52% | 26 |
|
|
2013
Q3 | $442M | Buy |
9,552,257
+523,667
| +6% | +$23M | 0.49% | 30 |
|
|
2013
Q2 | $403M | Buy |
+9,028,590
| New | +$392M | 0.48% | 30 |
|
Other funds holding BMY
VCM
VPM
Neuberger Berman Group's BMY Position: Q1 2026 in Review
Neuberger Berman Group increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $7.42M and bringing the position to 884,303 shares worth $53.6M. The position accounts for 0.04% of the portfolio, ranked #461.
Neuberger Berman Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $503M in Q4 2013. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Neuberger Berman Group held 884,303 shares of Bristol-Myers Squibb worth $53.6M as of Q1 2026.
- Neuberger Berman Group bought 127,273 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.42M.
- Bristol-Myers Squibb made up 0.04% of Neuberger Berman Group's portfolio in Q1 2026, its #461 holding.
- Neuberger Berman Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Bristol-Myers Squibb position peaked at $503M in Q4 2013.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.